Mutagen sensitivity as a marker of cancer susceptibility

Journal of Cellular Biochemistry

Volumn 63, Issue SUPPL. 25, 1996, Pages 80-84

  Spitz, Margaret R ^a,b   Wu, Xifeng ^a   Jiang, Hong ^a   Hsu, T C ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

bleomycin induced chromosome breakage; cancer susceptibility; lung cancer; minority populations; smoking

Indexed keywords

BLEOMYCIN; TUMOR MARKER; MUTAGENIC AGENT;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTAGEN TESTING; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; ADULT; GENETIC PREDISPOSITION; GENETICS; HISPANIC; LUNG TUMOR; MULTIVARIATE ANALYSIS; NEGRO; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MEXICAN AMERICANS; MULTIVARIATE ANALYSIS; MUTAGENICITY TESTS; MUTAGENS; SMOKING; TEXAS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030337994     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1996)25+<80::AID-JCB11>3.0.CO;2-R     Document Type: Article

References (22)

1. Shopland DR, Eyre HJ, Pechacek TF (1991): Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 83:1142-1148.
2. Sellers TA, Potter JD, Bailey-Wilson JE, Rich SS, Rothschild H, Elston RC (1992): Lung cancer detection and prevention: Evidence for an interaction between smoking and genetic predisposition. Cancer Res 52:2694s-2697s.
3. Iannuzzi MC, Miller YE (1986): Genetic predisposition to lung cancer. Semin Respir Med 7:327-333.
4. German J (1972): Genes which increase chromosomal instability in somatic cells and predispose to cancer. Prog Med Genet 8:61-102.
5. Paterson NC, Smith PJ (1979): Ataxia telangiectasia: An inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annu Rev Genet 13:291-318.
6. Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, Winn RJ, Shirley L, Furlong C (1989): Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis. Int J Cancer 43:403-409.
7. Cherry LM, Hsu TC (1983): Bleomycin-induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members. Anticancer Res 3:367-372.
8. Hsu TC, Cherry LM, Samaan NA (1985): Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet Cytogenet 17:307-313.
9. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR, Schantz SP (1989): Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 49:4626-4628.
10. Spitz MR, Fueger JJ, Halabi S, Schantz SP, Sample D, Hsu TC (1993): Mutagen sensitivity in upper aerodigestive tract cancer: Acase-control analysis. Cancer Epidemiol Biomarkers Prev 2:329-333.
11. Schantz SP, Spitz MR, Hsu TC (1990): Mutagen sensitivity in patients with head and neck cancers: A biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst 82:1773-1775.
12. Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, Bondy ML, Hong WK, Hsu TC (1994): Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst 86:1681-1684.
13. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA (1995): Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 4:99-103.
14. Strom SS, Wu XF, Sigurdson AJ, Hsu TC, Fueger JJ, Lopez J, Tee PG, Spitz MR (1995): Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. Monogr Natl Cancer Inst 18:29-34.
15. Cornfield J (1956): A statistical problem arising from retrospective studies. In Newman J (ed): "Proceedings of the 3rd Berkeley Symposium on Mathematical Statistics and Probability." Berkeley, CA: University of California Press, pp 135-148.
16. STATA (1993): "Release 3.1 Reference Manual," 6th Edition. Santa Monica, CA: Stata Corporation.
17. Wu X, Hsu TC, Annegers JF, Amos CI, Fueger JJ, Spitz MR (1995): A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res 55:557-561.
18. Wiencke JK, Spitz MR (1995): In vitro chromosomal assays of mutagen sensitivity and human cancer risk. Cancer Bull 47:83-85.
19. Hagmar L, Brøgger A, Hansteen I-L, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa S, Skerfving S, Sorsa M (1994): Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:2919-2922.
20. Nakachi K, Imai K, Hayashi S, Kawajiri K (1993): Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility of lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53:2994-2999.
21. Pandita TK, Hittelman WN (1995): Evidence of a chromatin basis for increased mutagen sensitivity associated with multiple primary malignancies of the head and neck. Int J Cancer, in press. 61:738-743.
22. Cloos J, Braakhuis BJM, Steen I, Cooper MP, de Vries N, Nauta JJP, Snow GB (1994): Increased mutagen sensitivity in head and neck squamous cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 56:816-819.